Mercuri, Eugenio Maria
 Distribuzione geografica
Continente #
EU - Europa 8.865
NA - Nord America 8.783
AS - Asia 1.583
SA - Sud America 57
AF - Africa 49
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
Totale 19.373
Nazione #
US - Stati Uniti d'America 8.718
DE - Germania 2.680
IT - Italia 1.697
SE - Svezia 1.557
CN - Cina 995
IE - Irlanda 668
UA - Ucraina 646
FR - Francia 489
GB - Regno Unito 334
IN - India 219
FI - Finlandia 201
PL - Polonia 166
BE - Belgio 74
RU - Federazione Russa 71
TR - Turchia 70
IR - Iran 66
NL - Olanda 52
HK - Hong Kong 50
JP - Giappone 45
SG - Singapore 42
CH - Svizzera 38
CA - Canada 37
CI - Costa d'Avorio 31
CZ - Repubblica Ceca 31
AU - Australia 26
ES - Italia 26
BR - Brasile 24
RO - Romania 21
AT - Austria 16
PH - Filippine 16
PA - Panama 15
EG - Egitto 14
KR - Corea 14
RS - Serbia 13
IL - Israele 12
MK - Macedonia 12
AR - Argentina 11
CL - Cile 9
DK - Danimarca 9
PT - Portogallo 9
HU - Ungheria 8
MX - Messico 8
NO - Norvegia 8
VN - Vietnam 8
A2 - ???statistics.table.value.countryCode.A2??? 7
GR - Grecia 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
BD - Bangladesh 6
CO - Colombia 6
BG - Bulgaria 5
HR - Croazia 5
MY - Malesia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
TW - Taiwan 4
EE - Estonia 3
KZ - Kazakistan 3
PR - Porto Rico 3
TH - Thailandia 3
AL - Albania 2
BT - Bhutan 2
LT - Lituania 2
MA - Marocco 2
ME - Montenegro 2
MO - Macao, regione amministrativa speciale della Cina 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GL - Groenlandia 1
ID - Indonesia 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
SM - San Marino 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.373
Città #
Chandler 2.020
Ashburn 832
Dublin 622
New York 436
Jacksonville 403
San Mateo 373
Rome 273
Nanjing 261
Wilmington 251
Milan 233
Marseille 212
Boston 209
Ann Arbor 192
Dearborn 183
Nürnberg 176
Woodbridge 156
Princeton 153
Houston 148
Warsaw 144
Fairfield 135
Lawrence 127
Redwood City 113
Seattle 113
Beijing 108
Munich 104
Bremen 102
Cattolica 99
Nanchang 96
Redmond 76
Los Angeles 70
Lancaster 67
Hebei 65
Norwalk 63
Brussels 59
Izmir 52
Mountain View 49
Shenyang 49
Detroit 48
Helsinki 47
Pune 45
Augusta 44
Chicago 44
Jiaxing 43
Changsha 41
University Park 41
Kish 40
Boardman 39
Hong Kong 39
Jinan 38
Leawood 37
Shanghai 36
Cambridge 33
Hangzhou 33
Palermo 32
Abidjan 31
Kunming 31
Tianjin 31
Zhengzhou 29
Guangzhou 28
Andover 26
Washington 26
London 25
Busto Arsizio 24
Fremont 24
Toronto 23
Edinburgh 22
Florence 20
Ningbo 18
San Francisco 16
Bologna 15
Hefei 15
Sydney 15
Turin 15
Brno 14
Messina 14
Monza 14
Inverigo 13
Madrid 13
Menlo Park 13
Simi Valley 13
São Paulo 13
Urbino 13
Bari 12
Philadelphia 12
San Diego 12
Singapore 12
Stockholm 12
Amsterdam 11
Prague 11
Bern 10
Clearwater 10
Padova 10
Seoul 10
Skopje 10
Cairo 9
Catania 9
Genoa 9
Phoenix 9
Taizhou 9
Tokyo 9
Totale 10.244
Nome #
Tele-riabilitazione con il Training Lettura Ritmica: Applicazione a distanza di un training ritmico-musicale per il potenziamento della lettura nella dislessia evolutiva 278
The visual function assessment: from birth to the follow up 264
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 250
Cortical visual function in preterm infants in the first year. 203
Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module 198
Enhanced human brain associative plasticity in Costello syndrome 189
Neurological examination of preterm infants a term equivalent age 183
Spinal muscular atrophy 182
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 159
Crossed cerebellar atrophy of prenatal onset 155
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 152
Prognostic value of EEG performed at term age in preterm infants. 147
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 147
Application of a neonatal assessment of visual function in a population of low risk full-term newborn. 141
-Thalamic atrophy in infants with PVL and cerebral visual impairment 135
Use of the Hammersmith Infant Neurological Examination in Infants With Cerebral Palsy: A Critical Review of the Literature 134
Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature. 126
Longitudinal assessment of perceptual-motor abilities in pre-school preterm children 123
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 120
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care? 119
Visual development in prenatal post-haemorragic ventricular dilatation 117
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 116
External hydrocephalus in discordant birth weight twins: a case report 116
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 114
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 114
Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome 112
Muscle MRI in Becker muscular dystrophy 110
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 110
Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy 110
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 months. 106
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 106
Early assessment of visual function in preterm infants: how early is early? 105
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 105
Development of clinical signs in low risk term born infants with neonatal hyperexcitability 105
DMD myogenic cells from urine-derived stem cells recapitulate the dystrophin genotype and phenotype 104
Neuropsychological development in children with Dravet syndrome. 101
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients 100
134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands. 100
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 98
Performance of Upper Limb module for Duchenne muscular dystrophy 98
Neuropsychological development in children with Dravet syndrome 97
Perceptual-motor abilities in pre-school preterm children 97
Long Term Memory Profile of Disorders Associated with Dysregulation of the RAS-MAPK Signaling Cascade. 96
Muscle MRI in Becker muscular dystrophy 96
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 95
Muscle MRI: Out of the tunnel. 94
Congenital muscular dystrophies with cognitive impairment. A population study 94
Neuropsychological development in children with Dravet syndrome 93
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 93
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine 92
Revised upper limb module for spinal muscular atrophy: Development of a new module 92
A current approach to heart failure in Duchenne muscular dystrophy 92
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study 91
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 91
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy 90
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 90
Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients 90
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 88
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands 87
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 85
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies 83
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 83
Application of a neonatal assessment of visual function in a population of low risk full-term newborn 82
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion 82
Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report 82
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 82
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. 81
Visual and visuoperceptual function in children with Panayiotopoulos syndrome 81
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 81
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 79
MRI: Out of the tunnel. 79
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 77
Assessing Joint Hypermobility in Preschool-Aged Children 77
The empowerment of translational research: lessons from laminopathies 77
Predominant distal muscle involvement in spinal muscular atrophy 76
Calf muscle involvement in Becker muscular dystrophy: When size does not matter 75
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 74
Behavioral profile in RASopathies 74
Cognitive-behavioral profiles in teenagers with Dravet syndrome 74
Childhood spinal muscular atrophy: controversies and challenges 73
Developmental milestones in type I spinal muscular atrophy 72
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 71
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 70
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 70
Auditory processing in infancy: do early abnormalities predict disorders of language and cognitive development? 68
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 68
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 67
173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands 66
Visual function assessment in late-preterm newborns. 66
Early visual and neuro-development in preterm infants with and without retinopathy 66
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 66
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 65
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 65
Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era 65
Developmental milestones in type I spinal muscular atrophy 64
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 64
Joint Laxity in Preschool Children Born Preterm 64
Children's healthcare during corona virus disease 19 pandemic: The Italian experience 64
Application of the Sleep Disturbance Scale for Children (SDSC) in infants and toddlers (6–36 months) 64
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 64
Totale 10.296
Categoria #
all - tutte 83.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019320 0 0 0 0 0 0 0 0 0 0 139 181
2019/20202.153 498 103 124 92 133 188 244 86 107 142 286 150
2020/20211.567 73 162 31 137 197 137 208 43 208 90 260 21
2021/20222.598 219 136 75 185 140 104 52 416 144 177 467 483
2022/20236.181 712 761 451 918 397 769 377 534 750 88 253 171
2023/20243.414 185 909 142 291 171 707 471 202 108 228 0 0
Totale 19.814